DNMT3B and neoplasm: Dnmt3b+/− lymphomas were likely monoclonal because most T-cells in the tumor uniformly expressed the same TCR receptor, e.g., TCR-vβ 5.1 to 5.2 in tumor 1 or TCR-vβ 7 in tumor 2 (Fig. 1E).